Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
R. Orsenigo
Observed names:
Orsenigo R,
Orsenigo, R,
Orsenigo, Roberto,
R Orsenigo,
Roberto Orsenigo
Institution:
Novartis (Italy)
Observed institutions:
Novartis (Switzerland),
University of Milan,
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico,
Novartis (Italy),
University of Florence
OpenAlex ID:
A5076516135
Secukinumab for moderate-to-severe palmoplantar pustular psoriasis: Results of the 2PRECISE study
2019
·
Ulrich Mrowietz
, Hervé Bachelez
, et al.
·
Journal of the American Academy of Dermatology
·
148
PDF
Secukinumab dosing optimization in patients with moderate‐to‐severe plaque psoriasis: results from the randomized, open‐label OPTIMISE study
2019
·
K. Reich
, L. Puig
, et al.
·
British Journal of Dermatology
·
67
Secukinumab Use in Patients with Moderate to Severe Psoriasis, Psoriatic Arthritis and Ankylosing Spondylitis in Real-World Setting in Europe: Baseline Data from SERENA Study
2020
·
Uta Kiltz
, Petros P. Sfikakis
, et al.
·
Advances in Therapy
·
37
PDF
Secukinumab Improves Patient Perception of Anxiety and Depression in Patients with Moderate to Severe Psoriasis: A Post hoc Analysis of the SUPREME Study
2020
·
M Talamonti
, G Malara
, et al.
·
Acta Dermato Venereologica
·
36
PDF
Secukinumab treatment leads to normalization of quality of life and disease symptoms in psoriasis patients with or without prior systemic psoriasis therapy: the PROSE study results
2020
·
M. Augustin
, E. Dauden
, et al.
·
Journal of the European Academy of Dermatology and Venereology
·
28
PDF
Alisporivir with peginterferon/ribavirin in patients with chronic hepatitis C genotype 1 infection who failed to respond to or relapsed after prior interferon‐based therapy: FUNDAMENTAL, a Phase II trial
2014
·
M. Buti
, R. Flisiak
, et al.
·
Journal of Viral Hepatitis
·
23
Efficacy and safety of secukinumab in moderate to severe palmoplantar pustular psoriasis over 148 weeks: Extension of the 2PRECISE study
2020
·
Ulrich Mrowietz
, Hervé Bachelez
, et al.
·
Journal of the American Academy of Dermatology
·
21
PDF
REFINE: A Randomized Trial Comparing Cyclosporine A and Tacrolimus on Fibrosis After Liver Transplantation for Hepatitis C
2014
·
G. Levy
, F.G. Villamil
, et al.
·
American Journal of Transplantation
·
17
PDF
Redetermination of the standard potential of the mercuric oxide electrode at temperatures between 283 and 363 K and the solubility product constant of mercuric hydroxide
1987
·
P. Longhi
, T. Mussini
, et al.
·
Journal of Applied Electrochemistry
·
16
Cilia‐Associated Respiratory (CAR) Bacillus Infection In Conventionally Reared Rabbits
1998
·
M. Caniatti
, L. Crippa
, et al.
·
Journal of Veterinary Medicine Series B
·
15
Secukinumab Exhibits Sustained and Stable Response in Patients with Moderate-to-Severe Psoriasis: Results from the SUPREME Study
2021
·
Antonio Costanzo
, Filomena Russo
, et al.
·
Acta Dermato Venereologica
·
14
Real-world evidence of biologic treatments in psoriatic arthritis in Italy: results of the CHRONOS (EffeCtiveness of biologic treatments for psoriatic artHRitis in Italy: an ObservatioNal lOngitudinal Study of real-life clinical practice) observational longitudinal study
2022
·
Delia Colombo
, Micol Frassi
, et al.
·
BMC Rheumatology
·
12
PDF
Baseline characteristics of patients with moderate‐to‐severe psoriasis according to previous systemic treatment exposure: the PROSE study population
2020
·
M. Augustin
, E. Dauden
, et al.
·
Journal of the European Academy of Dermatology and Venereology
·
12
PDF
821 Interferon (ifn)-free Alisporivir (alv) Has a Better Overall Safety Profile Compared to Ifn-containing Treatment: a Pooled Analysis of the Alv Development Program
2013
·
L. Griffel
, W. Bao
, et al.
·
Journal of Hepatology
·
12
Effectiveness of cyclosporine A in patients with moderate to severe plaque psoriasis in a real-life clinical setting in Italy: the TRANSITION study
2020
·
F. Marsili
, M. Travaglini
, et al.
·
Journal of Dermatological Treatment
·
11
PDF
Evidence that SMS 201-995 enhances the immunosuppressive effect of FK506
1998
·
C Perego
, D Lattuada
, et al.
·
International Journal of Immunopharmacology
·
9
Xenogeneic orthotopic liver transplantation from sheep to pig: delay of rejection by FUT 175 Infusion.
1996
·
B Gridelli
, S Gatti
, et al.
·
PubMed
·
7
A real-world economic analysis of biologic therapies for psoriatic arthritis in Italy: results of the CHRONOS observational longitudinal study
2022
·
Emanuela Zagni
, Micol Frassi
, et al.
·
BMC Health Services Research
·
6
PDF
Efficacy of Secukinumab in Psoriasis: Post Hoc Gender-Wise Analysis of the SUPREME Study
2023
·
Luca Stingeni
, Giovanna Malara
, et al.
·
Clinical Cosmetic and Investigational Dermatology
·
5
PDF
Glucose abnormalities in Asian patients with chronic hepatitis C
2015
·
Qingyan Bo
, Roberto Orsenigo
, et al.
·
Drug Design Development and Therapy
·
5
PDF
Conversion to rescue therapy with FK 506: data from eight liver transplant patients.
1994
·
P Reggiani
, R Orsenigo
, et al.
·
PubMed
·
4
Microbiological investigation on frozen rabbit semen
1994
·
G. Grilli
, R. Orsenigo
, et al.
·
4
OPeNet: an AI-based platform implemented to facilitate clinical reasoning by primary care practitioners, as well as the virtuous co-management of chronic patients during and after the COVID-19 pandemic in Italy
2022
·
Roberto Orsenigo
, Veronica Colombi
, et al.
·
Diagnosis
·
3
PDF
1421 Alisporivir (alv) Plus Peginterferon/ribavirin (pr) Achieves High Svr12 Rates Among Null Responders, Il28bct/tt and Cirrhotic Hcvg1 Patients (fundamental Study Interim Analysis)
2013
·
M. Buti
, R. Flisiak
, et al.
·
Journal of Hepatology
·
3
The CHRONOS Real-World Evidence of Biologic Treatments in Psoriatic Arthritis in Italy: A Post Hoc Gender Analysis.
2022
·
Delia Colombo
, Micol Frassi
, et al.
·
PubMed Central
·
2
Show more works
View as search
Works count:
48
Citation count:
529
H-index:
12
I10-index:
15
Year
Topic
Type